Healixia saw the light of day early 2020. Below you find all the past events of Healixia, and - for the sake of completeness - also of the former associations (ACRP, BAPU, BeAPP and BRAS) that joined forces within Healixia.
Past events
Webinar: Healixia essentials: what you should know about the RIP (Responsible person for Information and Publicity)
The how, the why and the who: all you would like to know about the RIP (Responsible for Information and Publicity) when working outside regulatory affairs. This webinar is aimed at life science professionals who are not necessarily familiar with the term or who would like to learn more on it.
Healixia Essentials: during several short sessions throughout the year, we tackle different terms, concepts or processes to keep all professionals up to speed with the essentials of the life sciences industry.
On behalf of the EUFEMED Board, you are kindly invited to the EUFEMED General Assembly 2022. It will be a virtual event; you will receive the dial-in information shortly.
As EUFEMED needs to register the attendees, we kindly ask you to confirm your presence by registering, if you are planning to attend (Healixia members only - login first to register).
Join us at the end of spring for an informal get-together, where you can meet long-known and new peers over some good food and drinks.
Don't miss the keynote by Thierry Geerts, Country Director at Google Belgium, on his book 'Homo Digitalis' and his view on the impact of digital revolution on healthcare! Every participant receives a copy of his book.
On the agenda:
Approval activity report and financials Healixia 2021
Approval action plan and budget Healixia 2022
Mandates Board Members: ‘discharge’, election Board 2023-2025
Program:
16h45: Registration
17h00: General Assembly
Webinar: IB for an early phase/FIH trial: more than just a regulatory document
This online workshop will discuss the IB (Investigator's Brochure) structure, content and quality as important topics for all parties involved in planning, set-up, conduct and interpretation of a clinical study. Some practical highlights will be shared on challenges on writing a “good” IB for a FIH/Early Phase trial on the one hand, and on how to use it for an optimal benefit-risk assessment on the other hand.
This two-day course is intended to provide an in depth knowledge and understanding of the main principles and concepts of the Quality part of the Common Technical Document.
This website makes use of cookies to function properly. If you would like to change which cookies we can use, change the cookie settings. Read more about our use of cookies in our privacy policy.